Original Article
30 October 2025 / 30 October 2025 by edra
Background. Seed Storage Proteins (SSPs) associate with severe allergic reactions to tree nuts, peanuts, and seeds. This study aimed to characterize the molecular and clinical profiles of SSP sensitization, in patients allergic to peanuts, tree nuts, and/or seeds and sensitized to 2S Albumins (2S) or 7S and 11S Globulins (7S and 11S, respectively). Methods. A […]
Read more »
10 October 2025 / 10 October 2025 by edra
Background. Triple therapy with inhaled corticosteroids (ICS), long-acting β₂-agonists (LABA), and long-acting muscarinic antagonists (LAMA) is recommended for severe asthma patients with uncontrolled symptoms. Single-inhaler triple therapy (SITT) may offer additional clinical and practical benefits. This study analyzes the clinical profiles of patients receiving LAMA-containing regimens using real-world data from the Italian Registry on Severe […]
9 October 2025 by edra
Background. Drug hypersensitivity reactions (DHRs) include allergic, exaggerated pharmacologic, and pseudoallergic reactions to medications. The basophil activation test (BAT) using CD63 expression is a sensitive and specific complementary tool in the diagnosis of immediate DHRs. Methods. In this study we analysed retrospectively 1160 patients with history of DHRs categorized into several subgroups of diagnoses. BAT […]
3 September 2025 by edra
Background. Chronic spontaneous urticaria (CSU) is a common disorder characterized by the recurrence of wheals and/or angioedema for more than 6 weeks. About 35% of patients experience wheals and angioedema (AE-CSU) and around 6% of patients only present angioedema, also known as chronic histaminergic angioedema (CHA). As few data comparing CHA and AE-CSU are published, […]
3 July 2025 / 3 July 2025 by edra
Background. Clinical and laboratory features of wheat allergy dependent on augmentation factor (WALDA) are scarcely characterised as compared to wheat anaphylaxis dependent on augmentation factor (WANDA). In this study we assessed the pattern of comorbid atopic and gastrointestinal diseases and the sensitisation profile in patients with WALDA presenting with intermittent urticaria. Methods. We retrospectively assessed […]
2 July 2025 by edra
HAE is a rare disease manifesting with recurrent attacks of disabling and potentially life-threatening angioedema for which early diagnosis and effective therapy are critical. Recent scientific progress and the development of novel therapeutic options has engendered multiple important changes in the diagnosis and management of the disease. In an attempt to encourage and facilitate the […]
2 July 2025 / 2 July 2025 by edra
Background. Mixed rhinitis (MR) is a potential diagnosis for patients with allergic rhinitis (AR) who present symptoms following exposure to allergens yet also exhibit a significant burden of symptoms after exposure to non-specific irritants. MR is thought to be more prevalent than the isolated form of the disease (AR). However, there are still no established […]
12 May 2025 by edra
Eosinophilic esophagitis (EoE) is a chronic inflammatory disease of the esophagus affecting mainly young individuals with a high burden of comorbid atopic diseases and is associated with increased morbidity. Proton pump inhibitors (PPIs) is often the first line of treatment by inducing clinical remission in 30-50% of patients. Recently new drugs, such as budesonide orodispersible […]
9 May 2025 / 14 May 2025 by edra
Background. Allergy is a multifactorial disease in which variant genetic and environmental factors are involved. Pathophysiology of food allergy (FA) and its natural history are poorly understood till now. Novel biomarkers and curative treatment options are strongly required. We aimed to study the significance of serum sphingosine 1 phosphate (S1P) level in food allergy and […]
29 April 2025 by edra
Background. Data on epidemiology of anaphylaxis are difficult to record. During the lockdown in 2020-2021 due to Coronavirus disease 2019 (COVID-19), referrals to Emergency Department (E.D.) reduced. The aims of the study are to determine anaphylaxis frequency before and during COVID-19 pandemic and risk factors for severity. Methods. Clinical records from a general E.D. of […]